Bone Marrow Reticulin Content In Acute Leukemia
DOI:
https://doi.org/10.32007/jfacmedbagdad.4831509Keywords:
acute leukemia, bone marrow biopsy, reticulin content.Abstract
Background: Increase in marrow reticulin has long been recognized in primary myelofibrosis, but little was known about the reticulin structure of leukemic marrows, there has been a tendency to accept an increase in marrow reticulin as evidence of myelofibrosis. Similarly, there has been a tendency to diagnose as "acute myelofibrosis" cases of acute leukemia with brisk reticulin and early collagen production. This study was undertaken to determine incidence, type and pattern of fibrosis in the bone marrow of patients with acute leukemia, both acute lymphoblastic and acute myeloid leukemia.
Method: thirty-five bone marrow biopsy specimens from patients with acute leukemia were examined histologically; connective tissue stains were applied for stromal studies.
Result: an increase in marrow reticulin is common at presentation in patients with acute leukemia, effective anti-leukemic therapy results in resolution of the increased marrow reticulin.
Conclusion: The reticulin type of fibrosis is the common type encountered in acute leukemia which is of diffuse pattern, higher incidence of bone marrow fibrosis in patients with acute lymphoblastic leukemia than those with acute myloid leukemia. Fiber bone formation is found in 10% of cases of acute lymphoblastic leukemia ,but is not extensive and well developed as in cases of primary myelofibrosis.
Downloads
Downloads
Published
Issue
Section
License
Permit others to copy and distribute the manuscript; to extract, revise, and create another derivative
works of or from the manuscript (e.g., a translation); to incorporate the manuscript into a
collective work; and to text or data mine the article, even for commercial purposes, provided that
the author(s) is/are credited; the article's modifications should not harm the author's honor or
reputation; and the article should not be altered in a way that would cause the author to lose them
reputation. The Creative Commons Attribution 4.0 International License (CC BY 4.0) has more
information.